Catalyst Wire Dossier Catalyst Wire Dossier

TDF-FTC (tenofovir disoproxil fumarate/emtricitabine)

tenofovir disoproxil fumarate and emtricitabine · Gilead Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TDF-FTC (tenofovir disoproxil fumarate/emtricitabine), covering 2024-08-12 to 2024-08-12. Get the full timeline:

Most recent: Clinical Trial Update: The Women TDF-FTC Benchmark Study [Phase 2]

See pricing